1-7 of 7
Robert B. Sims
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Trial-in-Progress: Brentuximab Vedotin in Combination with Lenalidomide and Rituximab in Subjects with Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL)

Nancy L. Bartlett, MD, Christopher A. Yasenchak, MD, Robert B. Sims, MD, Grzegorz S. Nowakowski, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 14.
https://doi.org/10.1182/blood-2020-136400
Published: 2020
Journal Articles

Trial-in-Progress: Frontline Brentuximab Vedotin and CHP (A+CHP) in Patients with Peripheral T-Cell Lymphoma with Less Than 10% CD30 Expression

Deepa Jagadeesh, MDMPH, Robert B. Sims, MD, Steven M. Horwitz, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 30.
https://doi.org/10.1182/blood-2020-136402
Published: 2020
Journal Articles

Frontline Brentuximab Vedotin As Monotherapy or in Combination for Older Hodgkin Lymphoma Patients

Christopher A. Yasenchak, MD, Rodolfo Bordoni, MD, Dipti Patel-Donnelly, MD, Timothy Larson, MD, Jerome Goldschmidt, MD, Ralph V. Boccia, MD, Vivian J.M. Cline, Mariana Sacchi, MD, Andres Forero-Torres, Robert B. Sims, MD, Jingmin Liu, Jonathan W. Friedberg, MD MSSc
Journal: Blood
Blood (2020) 136 (Supplement 1): 18–19.
https://doi.org/10.1182/blood-2020-136583
Published: 2020
Journal Articles

Matched Case Control Analysis Comparing Long Term Survival of Multiple Myeloma Patients Who Received Stem Cell Transplant with and without Idiotype-Pulsed Dendritic Cell Vaccine

Yi Lin, MD PhD, Morie A Gertz, MD, Robert B. Sims, MD, Sumithra Mandrekar, PhD, Kristina Laumann, Betsy LaPlant, Angela Dispenzieri, MD, Suzanne R Hayman, MD, Francis K Buadi, M.D., David Dingli, M.D., Ph.D., Douglas Padley, Dennis A. Gastineau, MD, Shaji Kumar, MD, Vincent Rajkumar, MD, Martha Q Lacy, MD
Journal: Blood
Blood (2011) 118 (21): 636.
https://doi.org/10.1182/blood.V118.21.636.636
Published: 2011
Journal Articles

Increased Gamma Globulin Following Immunotherapy with Sipuleucel-T Is Associated with Antigen-Specific Antibody Responses

Robert B. Sims, MD, Mark H. Wener, MD, Corazon P. dela Rosa, Lisa R. C. Lin, Nadeem A. Sheikh, PhD
Journal: Blood
Blood (2010) 116 (21): 1738.
https://doi.org/10.1182/blood.V116.21.1738.1738
Published: 2010
Journal Articles

Elevated Eosinophils Following Treatment with Sipuleucel-T In Men with Prostate Cancer Is Associated with Antigen-Specific Immune Response and Prolonged Survival.

Robert B. Sims, MD, Lisa R. C. Lin, Corazon P. dela Rosa, Nadeem A. Sheikh, PhD, James B. Whitmore, PhD, Mark W. Frohlich, MD
Journal: Blood
Blood (2010) 116 (21): 1491.
https://doi.org/10.1182/blood.V116.21.1491.1491
Published: 2010
Journal Articles

Phase 1 trial of a novel anti-CD20 fusion protein in pretargeted radioimmunotherapy for B-cell non-Hodgkin lymphoma

Clinical Trials & Observations
Andres Forero, Paul L. Weiden, Julie M. Vose, Susan J. Knox, Albert F. LoBuglio, Jordan Hankins, Michael L. Goris, Vincent J. Picozzi, Don B. Axworthy, Hazel B. Breitz, Robert B. Sims, Richard G. Ghalie, Sui Shen, Ruby F. Meredith
Journal: Blood
Blood (2004) 104 (1): 227–236.
https://doi.org/10.1182/blood-2003-09-3284
Published: 2004